血液透析单位中的丙型肝炎：医院内传播的分子证据。
Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission.
作者信息
Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A
机构信息
Département de Microbiologie Médicale et Moléculaire, CHU Bretonneau, 37044 Tours Cedex, France.
出版信息
J Clin Microbiol. 1998 Oct;36(10):3040-3. doi: 10.1128/JCM.36.10.3040-3043.1998.
Abstract
This study reports four cases of transmission of the rare hepatitis C virus genotype 4 which occurred in a hemodialysis unit and originated from a single source of infection. Phylogenetic analyses performed with the NS5b domain showed that all four patients with secondary infections were infected with virus strains very similar to that of the index patient. Cross infections probably resulted from breaches in safety precautions and lack of dialysis machine sterilization.
摘要
本研究报告了4例罕见的丙型肝炎病毒4型传播病例，这些病例发生在一个血液透析单元，且源于单一传染源。对NS5b结构域进行的系统发育分析表明，所有4例继发感染患者均感染了与首例患者病毒株非常相似的病毒。交叉感染可能是由于安全预防措施存在漏洞以及透析机未进行消毒所致。
相似文献
1
Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission.血液透析单位中的丙型肝炎：医院内传播的分子证据。
J Clin Microbiol. 1998 Oct;36(10):3040-3. doi: 10.1128/JCM.36.10.3040-3043.1998.
2
Monitoring hepatitis C infection in a major Swedish nephrology unit and molecular resolution of a new case of nosocomial transmission.监测瑞典一家大型肾病科的丙型肝炎感染情况，并对一例新的医院内传播病例进行分子解析。
J Med Virol. 2010 Feb;82(2):249-56. doi: 10.1002/jmv.21683.
3
Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit.
Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):182-6. doi: 10.1007/s100960050456.
4
Determining the source of nosocomial transmission in hemodialysis units in Tunisia by sequencing NS5B and E2 sequences of HCV.通过对丙型肝炎病毒（HCV）的NS5B和E2序列进行测序来确定突尼斯血液透析单位中医院内传播的源头。
J Med Virol. 2007 Aug;79(8):1089-94. doi: 10.1002/jmv.20877.
5
Evidence of association between hepatitis C virus genotype 2b and nosocomial transmissions in hemodialysis centers from southern Brazil.巴西南部血液透析中心丙型肝炎病毒 2b 基因型与医院内传播之间关联的证据。
Virol J. 2013 May 29;10:167. doi: 10.1186/1743-422X-10-167.
6
Investigation of a Case of Genotype 5a Hepatitis C Virus Transmission in a French Hemodialysis Unit Using Epidemiologic Data and Deep Sequencing.利用流行病学数据和深度测序对法国一家血液透析单位丙型肝炎病毒5a基因型传播病例的调查。
Infect Control Hosp Epidemiol. 2016 Feb;37(2):134-9. doi: 10.1017/ice.2015.263. Epub 2015 Oct 29.
7
A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit.
J Viral Hepat. 2002 Nov;9(6):450-4. doi: 10.1046/j.1365-2893.2002.00374.x.
8
Molecular evidence for nosocomial spread of two different hepatitis C virus strains in one hemodialysis unit.同一血液透析单元中两种不同丙型肝炎病毒株发生医院内传播的分子证据。
Nephron. 1997;77(3):273-8. doi: 10.1159/000190287.
9
Hepatitis C virus transmission in a Dutch haemodialysis unit: detailed outbreak investigation using NS5A gene sequencing.荷兰血液透析中心丙型肝炎病毒传播：使用 NS5A 基因测序的详细暴发调查。
J Hosp Infect. 2019 Mar;101(3):333-338. doi: 10.1016/j.jhin.2018.11.015. Epub 2018 Nov 27.
10
Phylogenetic analysis confirms hepatitis C virus transmission among hemodialysis patients in Kosovo.系统发育分析证实了科索沃血液透析患者中丙型肝炎病毒的传播。
J Infect Dev Ctries. 2019 Dec 31;13(12):1142-1149. doi: 10.3855/jidc.12099.
引用本文的文献
1
Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial.索磷布韦和达卡他韦治疗血液透析患者 1 型和 3 型丙型肝炎的疗效和耐受性：一项前瞻性干预性临床试验。
BMC Nephrol. 2019 Nov 28;20(1):438. doi: 10.1186/s12882-019-1631-4.
2
Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen.使用基于索磷布韦的方案治疗丙型肝炎的血液透析患者。
Kidney Int Rep. 2017 Apr 26;2(5):831-835. doi: 10.1016/j.ekir.2017.04.003. eCollection 2017 Sep.
3
Pegylated interferon monotherapy for hepatitis C virus infection in patients on hemodialysis: A single center study.聚乙二醇化干扰素单药治疗血液透析患者丙型肝炎病毒感染：一项单中心研究。
Indian J Nephrol. 2016 Jul-Aug;26(4):244-51. doi: 10.4103/0971-4065.172228.
4
Study of the Associations Between TT Virus Single and Mixed Infections With Leukemia.TT病毒单一感染及混合感染与白血病之间关联的研究
Jundishapur J Microbiol. 2015 Apr 18;8(4):e18212. doi: 10.5812/jjm.8(4)2015.18212. eCollection 2015 Apr.
5
Hepatitis C virus screening and management of seroconversions in hemodialysis facilities.血液透析机构中丙型肝炎病毒筛查及血清转化的管理
Semin Dial. 2013 Jul-Aug;26(4):439-46. doi: 10.1111/sdi.12097. Epub 2013 May 31.
6
Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.利比亚血液透析患者乙型和丙型肝炎感染：流行率、发生率和危险因素。
BMC Infect Dis. 2012 Oct 20;12:265. doi: 10.1186/1471-2334-12-265.
7
The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies.血液恶性肿瘤患者中肝炎病毒的分子和免疫感染标志物的流行情况。
Mol Biol Rep. 2012 Feb;39(2):1217-23. doi: 10.1007/s11033-011-0851-x. Epub 2011 May 20.
8
Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome.血液透析单位丙型肝炎病毒流行的分子流行病学：暴发调查和感染结果。
BMC Infect Dis. 2010 Aug 27;10:257. doi: 10.1186/1471-2334-10-257.
9
Hepatitis C virus infection in haemodialysis: the 'no-isolation' policy should not be generalized.血液透析中的丙型肝炎病毒感染：“不隔离”政策不应一概而论。
Nephron Clin Pract. 2009;111(2):c133-40. doi: 10.1159/000191208. Epub 2009 Jan 16.
10
Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay.采用新版INNO-LiPA HCV检测法改进丙型肝炎病毒（HCV）基因型测定
J Clin Microbiol. 2007 Apr;45(4):1140-5. doi: 10.1128/JCM.01982-06. Epub 2007 Jan 24.
本文引用的文献
1
Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping.用于丙型肝炎病毒基因分型的DNA酶免疫测定法与线性探针测定法（Inno-LiPA HCV I和II）的比较。
J Clin Microbiol. 1998 May;36(5):1461-3. doi: 10.1128/JCM.36.5.1461-1463.1998.
2
Transmission of the hepatitis C virus in an hemodialysis unit: evidence for nosocomial infection.丙型肝炎病毒在血液透析单位的传播：医院感染的证据。
Clin Nephrol. 1997 Apr;47(4):263-70.
3
Nosocomial transmission of hepatitis C virus in haemodialysis patients.丙型肝炎病毒在血液透析患者中的医院内传播。
J Med Virol. 1996 Aug;49(4):296-302. doi: 10.1002/(SICI)1096-9071(199608)49:4<296::AID-JMV7>3.0.CO;2-Z.
4
Second-generation line probe assay for hepatitis C virus genotyping.第二代丙型肝炎病毒基因分型线探针检测法
J Clin Microbiol. 1996 Sep;34(9):2259-66. doi: 10.1128/jcm.34.9.2259-2266.1996.
5
Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.通过5'-UR/核心线探针检测法进行丙型肝炎病毒基因分型及对无法分型样本的分子分析。
Virus Res. 1995 Oct;38(2-3):137-57. doi: 10.1016/0168-1702(95)00052-r.
6
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.通过对NS-5区域进行系统发育分析，将丙型肝炎病毒分为六个主要基因型和一系列亚型。
J Gen Virol. 1993 Nov;74 ( Pt 11):2391-9. doi: 10.1099/0022-1317-74-11-2391.
7
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin.
Lancet. 1995 May 13;345(8959):1211-3. doi: 10.1016/s0140-6736(95)91993-7.
8
Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.不同人群中丙型肝炎病毒（HCV）抗体阳性者的HCV病毒血症患病率及其意义。
J Clin Microbiol. 1993 May;31(5):1189-93. doi: 10.1128/jcm.31.5.1189-1193.1993.
9
Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment.
J Med Virol. 1994 Aug;43(4):415-9. doi: 10.1002/jmv.1890430417.
10
Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
Nephron. 1994;66(4):470-3. doi: 10.1159/000187867.
Zotero 插件